Interferon alfa-2b Product Approval Information - Licensing Action 11/6/97

Proper name: Interferon alfa-2b
Tradename: Intron A
Manufacturer: Schering Corp, Kenilworth, NJ, License #0994
Indication for Use: Use in conjunction with chemotherapy in patients with follicular lymphoma
Approval Date: 11/6/1997
Type of submission: Biologics license supplement


Clinical Review (PDF)
Labeling (PDF)

Page Last Updated: 04/01/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English